Mining the genome for drugs.
Wickelgren
I
I
D000818:Animals; D051017:Apoptosis Regulatory Proteins; D001709:Biotechnology; D019742:Chemokines, CC / Q000235:genetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004345:Drug Industry; D016228:Endothelial Growth Factors / Q000235:genetics; D051526:Fibroblast Growth Factor 10; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors; D015316:Genetic Therapy; D005826:Genetics, Medical; D015894:Genome, Human; D006023:Glycoproteins / Q000235:genetics / Q000627:therapeutic use; D006133:Growth Substances / Q000235:genetics / Q000627:therapeutic use; D006801:Humans; D008222:Lymphokines / Q000235:genetics; D008562:Membrane Glycoproteins / Q000235:genetics / Q000627:therapeutic use; D053244:Osteoprotegerin; D011506:Proteins / Q000235:genetics / Q000627:therapeutic use*; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D051017:Apoptosis Regulatory Proteins; C105504:CCL23 protein, human; D019742:Chemokines, CC; D016228:Endothelial Growth Factors; C496453:FGF7 protein, human; D051526:Fibroblast Growth Factor 10; D006023:Glycoproteins; D006133:Growth Substances; D008222:Lymphokines; D008562:Membrane Glycoproteins; D053244:Osteoprotegerin; D011506:Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; D053221:TNF-Related Apoptosis-Inducing Ligand; C506030:TNFRSF11B protein, human; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors